CHF44.02
0.53% day before yesterday
SIX Swiss Exchange, Jun 06, 05:31 pm CET
ISIN
CH1243598427
Symbol
SDZ
Index
Sector
Industry

Sandoz Stock price

CHF44.02
+7.13 19.33% 1M
+5.66 14.76% 6M
+6.85 18.43% YTD
+12.37 39.08% 1Y
+14.52 49.22% 5Y
+14.52 49.22% 10Y
+14.52 49.22% 20Y
SIX Swiss Exchange, Closing price Fri, Jun 06 2025
+0.23 0.53%
ISIN
CH1243598427
Symbol
SDZ
Index
Sector
Industry

Key metrics

Market capitalization CHF19.27b
Enterprise Value CHF22.29b
EV/Sales (TTM) EV/Sales 2.61
P/S ratio (TTM) P/S ratio 2.26
P/B ratio (TTM) P/B ratio 2.83
Dividend yield 1.36%
Last dividend (FY24) CHF0.60
Revenue (TTM) Revenue CHF8.54b
EBIT (operating result TTM) EBIT CHF252.35m
Cash position CHF979.00m
EPS (TTM) EPS CHF0.00
P/E forward 25.89
P/S forward 2.18
EV/Sales forward 2.52
Show more

Is Sandoz a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

Sandoz Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Sandoz forecast:

12x Buy
71%
5x Hold
29%

Analyst Opinions

17 Analysts have issued a Sandoz forecast:

Buy
71%
Hold
29%

Financial data from Sandoz

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
8,536 8,536
-
100%
- Direct Costs 4,486 4,486
-
53%
4,049 4,049
-
47%
- Selling and Administrative Expenses 2,000 2,000
-
23%
- Research and Development Expense 766 766
-
9%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 252 252
-
3%
Net Profit - -
-
-

In millions CHF.

Don't miss a Thing! We will send you all news about Sandoz directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sandoz Stock News

AD HOC NEWS
6 days ago
Der Pharmakonzern Sandoz CH1243598427 hat den Marktstart von zwei neuen Biosimilars in den USA bekannt gegeben.

Company Profile

Sandoz Group AG engages in focusing on generic pharmaceuticals and bio similar medical products. It acquires, manages and sells investments and intellectual property in the healthcare and medical device industry and conducts all business at home and abroad. The firm can acquire, sell, debit and manage interests in other companies, intellectual property rights and real estate at home and abroad, as well as establish branches and subsidiaries at home and abroad. The company was founded on January 17, 2022 and is headquartered in Rotkreuz, Switzerland.

Head office Switzerland
CEO Mr. Saynor
Employees 22,633
Founded 2022
Website www.sandoz.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today